Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study.

Belayneh Kefale Gelaw Melaku Tadege EngidawDesalegn TesfaMulugeta MollaGobezie T Tegegne

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

More than half of patients with cervical cancer had one or more MRPs. Being older, patients taking polypharmacy, stage III and IV patients were significantly associated with the development of MRPs. As most of the cervical patients experienced one or more MRPs, clinical pharmacy service should be strengthened to optimize drug therapy to reduce unwanted adverse events.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
mental health
healthcare
chronic kidney disease
peritoneal dialysis
prognostic factors
stem cells
adverse drug
palliative care
emergency department
patient reported outcomes
young adults
drug induced